April 06, 2024
1 min watch
Save
VIDEO: iDose TR launches, receives permanent J-code
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
BOSTON — In this Healio Video Perspective from the ASCRS meeting, Cody McKenzie of Glaukos discusses the anticipated impact of the iDose TR, which launched during the meeting.
He also announced that the travoprost intracameral implant, indicated for the reduction of IOP in open-angle glaucoma or ocular hypertension, received a permanent J-code, J7355, from CMS. The code will go into effect July 1.
“That will enable broader patient access as well as facilitate smooth claims processing,” McKenzie said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
McKenzie reports being the vice president and franchise head of glaucoma at Glaukos.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.